Audrey Clark
Acute Care · Albuquerque, NMNPI 1598307530
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Edwards Lifesciences at 51.8% of the total. Reporting peaked in 2021 at $1,366 and has fallen 97.7% since, to $31 in 2023.
Across 31 payments — averaging $71.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- Medtronic$751
- Getinge USA Sales, LLC$104
- Johnson & Johnson$83
- Abiomed$32
- W. L. Gore & Associates, Inc.$31
- plus $70 from 3 others
What the payments were for
- Travel & lodging$93442%
- Food & beverage$1,28158%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 12 | $1,152 |
| Medtronic | 9 | $751 |
| Getinge USA Sales, LLC | 2 | $104 |
| Johnson & Johnson(2 entities) | 2 | $83 |
| Abiomed | 1 | $32 |
| W. L. Gore & Associates, Inc. | 1 | $31 |
| Angiodynamics, Inc. | 2 | $28 |
| Atricure, Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,223 in reported general payments places this provider in the 85th percentile of 132 acute care providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other acute care in Albuquerque
- Taryn DenezpiAlbuquerque$11K
- Catherine MahoneyAlbuquerque$10K
- Samantha MatteucciAlbuquerque$8K
- Isabel TorresAlbuquerque$5K
- Kalina CordovaAlbuquerque$4K
- Marissa PettitAlbuquerque$3K
- Christine ObergAlbuquerque$3K
- Robyn MitchellAlbuquerque$2K
- Jessica KnightAlbuquerque$2K
- John MackenzieAlbuquerque$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.